Expression of secretory leukocyte protease inhibitor detected by immunohistochemistry correlating with prognosis and metastasis in colorectal cancer

BACKGROUND: The potential of secretory leukocyte protease inhibitor (SLPI) as a biomarker for colorectal cancer was studied. A prospective, randomized, controlled, clinical trial was conducted in 2013 and 2014 to confirm whether the expression of SLPI correlates with prognosis and metastasis in colo...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Guiying, Yang, Jingyan, Zhao, Yulei, Wang, Zhijing, Xing, Baoheng, Wang, Liang, Shi, Dongliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265488/
https://www.ncbi.nlm.nih.gov/pubmed/25441765
http://dx.doi.org/10.1186/1477-7819-12-369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265488/
https://www.ncbi.nlm.nih.gov/pubmed/25441765
http://dx.doi.org/10.1186/1477-7819-12-369

Ejemplares similares